Jazz Pharmaceuticals plc

13F holders, Q1 2024 (March 31)
1holders
$120.42avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Jazz Pharmaceuticals plc in their 13F filings. The largest holder was Firsthand Capital Management, Inc. ($14K).

Company
Jazz Pharmaceuticals plc
CUSIP
472147107
Latest filing quarter
Q1 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions1$14K
Exits0$0

Ownership 1 holders

Firsthand Capital Management, Inc. 0.02% New 120 $14K

"% of holder's portfolio" is Jazz Pharmaceuticals plc's weight in each manager's 13F, not the share of Jazz Pharmaceuticals plc the manager owns.